• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Impact of Diabetes on Exercise Tolerance in Patients After Cardiovascular Events.糖尿病对心血管事件后患者运动耐量的影响。
J Clin Med. 2025 Aug 7;14(15):5561. doi: 10.3390/jcm14155561.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
4
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
Pulmonary rehabilitation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺康复治疗
Cochrane Database Syst Rev. 2015 Feb 23;2015(2):CD003793. doi: 10.1002/14651858.CD003793.pub3.
6
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.司美格鲁肽对比安慰剂在射血分数轻度降低或保留的心衰患者中的疗效:SELECT、FLOW、STEP-HFpEF 和 STEP-HFpEF DM 随机试验的汇总分析。
Lancet. 2024 Sep 7;404(10456):949-961. doi: 10.1016/S0140-6736(24)01643-X. Epub 2024 Aug 30.
7
Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.循环长链酰基辅酶 A 与糖尿病心力衰竭结局:HF-ACTION 临床试验子研究。
Cardiovasc Diabetol. 2021 Aug 3;20(1):161. doi: 10.1186/s12933-021-01353-z.
8
Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.针对晚期疾病成年患者肌肉无力的神经肌肉电刺激
Cochrane Database Syst Rev. 2016 Oct 17;10(10):CD009419. doi: 10.1002/14651858.CD009419.pub3.
9
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
10
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial.司美格鲁肽用于射血分数保留的肥胖相关心力衰竭和2型糖尿病患者(跨越基线糖化血红蛋白水平)(STEP-HFpEF DM):一项来自随机、安慰剂对照试验的心力衰竭和代谢结局的预设分析
Lancet Diabetes Endocrinol. 2025 Mar;13(3):196-209. doi: 10.1016/S2213-8587(24)00304-8. Epub 2025 Jan 20.

本文引用的文献

1
Cardiac rehabilitation in ACHD: Further investment is now due.先天性心脏病的心脏康复:现在需要进一步投入。
Int J Cardiol Congenit Heart Dis. 2024 Dec 31;19:100564. doi: 10.1016/j.ijcchd.2024.100564. eCollection 2025 Mar.
2
Cardiopulmonary Exercise Testing: Methodology, Interpretation, and Role in Exercise Prescription for Cardiac Rehabilitation.心肺运动试验:方法、解读及其在心脏康复运动处方中的作用
US Cardiol. 2024 Dec 20;18:e22. doi: 10.15420/usc.2024.37. eCollection 2024.
3
Correction to: Determinants of double product: a cross-sectional study of urban residents in Japan.对《双乘积的决定因素:日本城市居民的横断面研究》的更正
Environ Health Prev Med. 2023;28:74. doi: 10.1265/ehpm.23-00220.
4
Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes.探索糖尿病与心血管疾病之间的复杂联系:分析降低糖尿病患者心血管风险的方法。
Cureus. 2023 Aug 21;15(8):e43882. doi: 10.7759/cureus.43882. eCollection 2023 Aug.
5
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.2023年欧洲心脏病学会糖尿病患者心血管疾病管理指南
Eur Heart J. 2023 Oct 14;44(39):4043-4140. doi: 10.1093/eurheartj/ehad192.
6
Where to Start? Physical Assessment, Readiness, and Exercise Recommendations for People With Type 1 or Type 2 Diabetes.从何处开始?1型或2型糖尿病患者的身体评估、准备情况及运动建议
Diabetes Spectr. 2023 May;36(2):105-113. doi: 10.2337/dsi22-0016. Epub 2023 May 15.
7
Prognostic Significance of Peak Workload-to-Weight Ratio by Cardiopulmonary Exercise Testing in Chronic Heart Failure.慢性心力衰竭患者心肺运动试验中峰值工作量与体重比的预后意义
Am J Cardiol. 2023 Apr 15;193:37-43. doi: 10.1016/j.amjcard.2023.01.052. Epub 2023 Mar 1.
8
Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults.全身免疫炎症指数(SII)、系统炎症反应指数(SIRI)与全因死亡率及心血管死亡率风险:一项对42875名美国成年人的20年随访队列研究
J Clin Med. 2023 Jan 31;12(3):1128. doi: 10.3390/jcm12031128.
9
Heart Rate Recovery (HRR) Is Not a Singular Predictor for Physical Fitness.心率恢复(HRR)不是体能的单一预测指标。
Int J Environ Res Public Health. 2022 Dec 31;20(1):792. doi: 10.3390/ijerph20010792.
10
Influence of Risk Factors on Exercise Tolerance in Patients after Myocardial Infarction-Early Cardiac Rehabilitation in Poland.危险因素对心肌梗死后患者运动耐量的影响——波兰的早期心脏康复
J Clin Med. 2022 Sep 23;11(19):5597. doi: 10.3390/jcm11195597.

糖尿病对心血管事件后患者运动耐量的影响。

The Impact of Diabetes on Exercise Tolerance in Patients After Cardiovascular Events.

作者信息

Czechowska Beata, Chrzczanowicz Jacek, Gawor Rafał, Zarzycka Aleksandra, Kostka Tomasz, Kostka Joanna

机构信息

Department of Methodology of Teaching Movement, Medical University of Lodz, Pl. Hallera 1, 90-647 Lodz, Poland.

Cardiac Rehabilitation Centre, Copernicus Memorial Hospital, Popioly 40, 93-438 Lodz, Poland.

出版信息

J Clin Med. 2025 Aug 7;14(15):5561. doi: 10.3390/jcm14155561.

DOI:10.3390/jcm14155561
PMID:40807182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12347737/
Abstract

: Diabetes mellitus (DM) is a significant factor affecting prognosis and functional capacity in patients after cardiovascular events. This study aimed to assess the impact of coexisting diabetes on exercise tolerance and hemodynamic parameters in patients qualified for cardiac rehabilitation. : A total of 452 patients (86 women, 366 men; mean age 63.21 ± 7.16 years) who had experienced cardiovascular incidents, including 226 individuals with coexisting DM (DM group) and 226 age- (±1 year) and sex-matched individuals without DM (non-DM group), were included in the analysis. All participants underwent an exercise test using a bicycle ergometer. Clinical data, comorbidities, medication use, left ventricular ejection fraction, and exercise test parameters were evaluated. : Patients with DM displayed a higher number of comorbidities (4.29 ± 1.26 vs. 3.19 ± 1.30; < 0.001), greater medication use (8.71 ± 2.16 vs. 7.83 ± 2.05; < 0.001), higher body mass (86.93 ± 13.35 kg vs. 80.92 ± 15.25 kg; < 0.001), and a lower left ventricular ejection fraction (48.78 ± 8.99% vs. 50.01 ± 8.40%; = 0.002) compared to those in the non-DM group. Diabetic patients also exhibited lower exercise capacity, expressed as peak power per kilogram of body mass (1.05 ± 0.27 W/kg vs. 1.16 ± 0.31 W/kg; < 0.001). No significant differences were observed regarding absolute peak power or maximum heart rate. : In patients after cardiovascular incidents, the presence of diabetes is associated with reduced relative exercise capacity and lower ejection fraction.

摘要

糖尿病(DM)是影响心血管事件后患者预后和功能能力的重要因素。本研究旨在评估并存糖尿病对符合心脏康复条件患者运动耐量和血流动力学参数的影响。

共有452例经历过心血管事件的患者(86例女性,366例男性;平均年龄63.21±7.16岁)纳入分析,其中包括226例并存糖尿病患者(糖尿病组)和226例年龄(±1岁)和性别匹配的非糖尿病患者(非糖尿病组)。所有参与者均使用自行车测力计进行运动测试。评估临床数据、合并症、药物使用情况、左心室射血分数和运动测试参数。

与非糖尿病组相比,糖尿病患者的合并症数量更多(4.29±1.26对3.19±1.30;P<0.001),药物使用量更大(8.71±2.16对7.83±2.05;P<0.001),体重更高(86.93±13.35 kg对80.92±15.25 kg;P<0.001),左心室射血分数更低(48.78±8.99%对50.01±8.40%;P = 0.002)。糖尿病患者的运动能力也较低,以每千克体重的峰值功率表示(1.05±0.27 W/kg对1.16±0.31 W/kg;P<0.001)。在绝对峰值功率或最大心率方面未观察到显著差异。

在心血管事件后的患者中,糖尿病的存在与相对运动能力降低和射血分数降低有关。